Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

OMEPRAZOLE EXTENDED-RELEASE CAPSULES

Awarded
SPE2DP26F8237Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8237 for the delivery of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716 and PR 7017631817, with a total contract value of $43.60. The award was issued on July 24, 2026, and falls under the broader delivery order SPE2DX25D9900, indicating this is a specific fulfillment within a larger procurement framework. The contract is categorized as a federal award with no set-aside designation, and the product is being supplied to meet Defense Department requirements. The awardee, DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0, is contractually obligated to deliver the specified medication, which is critical for medical use within federal operations. The place of performance and point of contact details are not provided, but the contract originates from the U.S. Department of Defense and is managed through the DIBBS procurement system. The award notice is accessible via the provided DIBBS link, and all procedural details are tied to this specific transaction under the agency’s supply chain for pharmaceuticals.

General Info

DMS PHARMACEUTICAL GROUP INC to deliver OMEPRAZOLE capsules for $43.60 under DLA contract SPE2DP26F8237.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

Contract Value

$43.6

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INCView Profile

Award Issued Date

Documents

(2)

SPE2DP26F8237.pdf

PDF

SPE2DP26F8237.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8237 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $43.60 Award Date: 07-24-2026 Delivery order under: SPE2DX25D9900 Line items: - OMEPRAZOLE EXTENDED-RELEASE CAPSULES (NSN/Part 6505013142716, PR 7017631817)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS